IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Cancer Genomics & Proteomics


ONLINE ISSN: 1790-6245new_highwire_logo


Cancer Genomics & Proteomics (CGP) is an international online-only open access, peer reviewed bimonthly journal devoted to the rapid publication of original high quality articles and reviews on the applications of genomic and proteomic technology to experimental and clinical cancer research. CGP was established in 2004.

Impact factor (2019): 3.280
Total articles: 47
Total cites: 894

Special issue of CANCER GENOMICS AND PROTEOMICS on “DNA Replication,
Genome Stability and Cell Cycle Control”

Dedicated to the study of DNA replication and the maintenance of genome stability, processes that are intrinsically linked to the cell cycle and cell division. This issue will focus on mechanisms that ensure proper DNA replication including licensing and replication machineries as well as cell cycle dynamics and genomic instability. The latter is now considered to play a key role in carcinogenesis.

Topics include but are not limited to:

      • Genomic instability in precancerous and cancer cells
      • DNA replication
      • Replication licensing
      • DNA damage response
      • Chromosomal instability
      • DNA repair pathways
      • p53 signaling
      • Cell cycle checkpoints
      • Apoptosis
      • Oncogene-induced genomic instability
      • Proteomic instability
      • Role of microRNAs in cancer
      • Homologous recombination deficiency (HRD)
      • Mismatch-repair (MMR) deficiency
      • Microsatellite instability (MSI)

Deadline for manuscript submission: April 7, 2021. Publication in May 2021.

Cancer Genomics & Proteomics is published online-only with open-access through HighWire Press.

Contents of Current Issue

  • 2004 – 2020
  • 17 volumes
  • over 6,760 pages
  • over 520 open access original articles
  • 95 open access reviews
  • over 3,000 authors
  • conference abstracts
  • author and subject detailed indexes
  • included in all abstracting services
  • online open access with HighWire Press
  • safe processing of all submitted manuscripts
  • rapid publication within 1-2 months of acceptance
  • no fees for language and style corrections
  • immediate contact with the Editorial Office

111 Bay Avenue, Highlands, NJ 07732, USA.

Information – Editorial & Production Office:
Managing Editor: G. J. Delinasios, International Institute of Anticancer Research,
1st km Kapandritiou- Kalamou Rd., P.O.Box 22, Kapandriti, Attiki 19014, Greece.
Tel & Fax : +30-22950-52945, +30-22950-53389

IMPORTANT NOTE: You may submit your article only through our online submission system